SMARCB1 and neoplasm: Rhabdoid tumors with specific SWI/SNFc subunit mutations (mostly SMARCB1 and SMARCA4) have been shown to be associated with immune infiltration in the tumor microenvironment, monocytes/macrophages and CD8+ T lymphocytes being the two most predominant subtypes.